Expertise in
17
conditions

Dr. Justin Bottsford

Oncology
Praxis Pain Solutions Inc.
905 Highland Blvd Ste 4500, 
Bozeman, MT 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
17
conditions
Praxis Pain Solutions Inc.
905 Highland Blvd Ste 4500, 
Bozeman, MT 

Overview

Justin Bottsford is an Oncologist in Bozeman, Montana. Dr. Bottsford is highly rated in 17 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy.

His clinical research consists of co-authoring 32 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Oncology

Licenses

Obstetrics & Gynecology in MT

Hospital Affiliations

Bozeman Health Deaconess Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Mountain Health
  • OTHER COMMERCIAL
  • POS
  • PPO
Network Health
  • HMO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Praxis Pain Solutions Inc.
905 Highland Blvd Ste 4500, Bozeman, MT 59715
Other Locations
Billings Clinic
801 N 29th St, Billings, MT 59101

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Patients With Select Solid Tumors
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Patients With Select Solid Tumors
Enrollment Status: Recruiting
Publish Date: March 26, 2025
Intervention Type: Biological
Study Drugs: VV1, Cemiplimab
Study Phase: Phase 2
A Phase I/II Study Evaluating the Dosing, Safety, Efficacy, and Biological Activity of Intraperitoneal IMNN-001 (IL-12 Plasmid Formulated With PEG-PEI-Cholesterol Lipopolymer) Administered in Combination With Neoadjuvant Chemotherapy (NACT) in Patients Newly Diagnosed With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
A Phase I/II Study Evaluating the Dosing, Safety, Efficacy, and Biological Activity of Intraperitoneal IMNN-001 (IL-12 Plasmid Formulated With PEG-PEI-Cholesterol Lipopolymer) Administered in Combination With Neoadjuvant Chemotherapy (NACT) in Patients Newly Diagnosed With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 12, 2026
Intervention Type: Drug, Biological
Study Drugs: GEN-1, Carboplatin, Paclitaxel
Study Phase: Phase 1/Phase 2
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2025
Intervention Type: Drug
Study Drugs: Niraparib, Dostarlimab
Study Phase: Phase 3
A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax®-TF-ADC) Monotherapy and in Combination With Other Agents in Subjects With Recurrent or Stage IVB Cervical Cancer
A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax®-TF-ADC) Monotherapy and in Combination With Other Agents in Subjects With Recurrent or Stage IVB Cervical Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 12, 2025
Intervention Type: Drug
Study Drugs: Tisotumab Vedotin, Bevacizumab, Pembrolizumab, Carboplatin
Study Phase: Phase 1/Phase 2
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Upifitamab rilsodotin
Study Phase: Phase 1/Phase 2
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
Enrollment Status: Completed
Publish Date: April 05, 2023
Intervention Type: Drug, Biological
Study Drugs: Vigil Tumor Cells, Atezolizumab
Study Phase: Phase 2
View 5 Less Clinical Trials

32 Total Publications

Multi-Institutional Study of Referral Patterns for Gynecologic Oncology Consultation.
Multi-Institutional Study of Referral Patterns for Gynecologic Oncology Consultation.
Journal: JCO oncology practice
Published: May 22, 2024
Similar Doctors
Expertise in
43
conditions
Dr. Justin Thomas
Oncology
Expertise in
43
conditions
Dr. Justin Thomas
Oncology

Bozeman Radiation Oncology PC

931 Highland Blvd Ste 3130, 
Bozeman, MT 
 (12.4 miles away)
406-414-5070
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Justin Thomas is an Oncologist in Bozeman, Montana. Dr. Thomas is highly rated in 43 conditions, according to our data. His top areas of expertise are Appendix Cancer, Neuroendocrine Tumor, Familial Colorectal Cancer, and Anaplastic Large Cell Lymphoma.

Expertise in
34
conditions
Dr. Kenneth May
Hematology | Oncology
Expertise in
34
conditions
Dr. Kenneth May
Hematology | Oncology

Bozeman Radiation Oncology PC

931 Highland Blvd Ste 3130, 
Bozeman, MT 
 (12.4 miles away)
406-585-5070
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kenneth May is a Hematologist and an Oncologist in Bozeman, Montana. Dr. May is highly rated in 34 conditions, according to our data. His top areas of expertise are Neuroendocrine Tumor, Angiosarcoma, Inflammatory Breast Cancer, and Large-Cell Immunoblastic Lymphoma.

Expertise in
32
conditions
Dr. Annie Castillo
Hematology | Oncology
Expertise in
32
conditions
Dr. Annie Castillo
Hematology | Oncology

Bozeman Radiation Oncology PC

931 Highland Blvd Ste 3130, 
Bozeman, MT 
 (12.4 miles away)
406-556-5535
Languages Spoken:
English
See accepted insurances

Annie Castillo is a Hematologist and an Oncologist in Bozeman, Montana. Dr. Castillo is highly rated in 32 conditions, according to our data. Her top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Paget Disease of the Breast, and Lynch Syndrome.

Frequently Asked Questions about Dr. Justin Bottsford

How do I make an appointment with Dr. Justin Bottsford?

You can book an appointment with Dr. Justin Bottsford by calling their office at 406-414-5150. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Justin Bottsford a top-rated expert for Ovarian Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Justin Bottsford is classified as an Elite expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Justin Bottsford specialize in?

While Dr. Justin Bottsford is a Oncology, they have specific expertise in Ovarian Cancer, Endometrial Cancer, and Malignant Mixed Mullerian Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Justin Bottsford participate in research or clinical trials?

Yes. Dr. Justin Bottsford has published 32 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Dr. Justin Bottsford's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Justin Bottsford accept my insurance?

Dr. Justin Bottsford accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 406-414-5150 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bottsford's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 8 Advanced Conditions
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile